Literature DB >> 32472257

Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.

Hersh Shroff1, Mary E Rinella2.   

Abstract

Entities:  

Year:  2021        PMID： 32472257     DOI： 10.1007/s10620-020-06322-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  Understanding and managing cardiovascular outcomes in liver transplant recipients.

Authors:  Manhal Izzy; Lisa B VanWagner; Samuel S Lee; Mario Altieri; Mounika Angirekula; Kymberly D Watt
Journal:  Curr Opin Organ Transplant       Date:  2019-04       Impact factor: 2.640

Review 2.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

3.  Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.

Authors:  Lisa B Vanwagner; Manali Bhave; Helen S Te; Joe Feinglass; Lisa Alvarez; Mary E Rinella
Journal:  Hepatology       Date:  2012-11       Impact factor: 17.425

4.  Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness.

Authors:  Murat Sunbul; Mehmet Agirbasli; Erdal Durmus; Tarik Kivrak; Hakan Akin; Yucel Aydin; Rabia Ergelen; Yusuf Yilmaz
Journal:  Atherosclerosis       Date:  2014-10-17       Impact factor: 5.162

5.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

6.  Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.

Authors:  Donghee Kim; Adeyinka C Adejumo; Eric R Yoo; Umair Iqbal; Andrew A Li; Edward A Pham; George Cholankeril; Jeffrey S Glenn; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2019-06-25       Impact factor: 22.682

7.  Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.

Authors:  L B VanWagner; M Serper; R Kang; J Levitsky; S Hohmann; M Abecassis; A Skaro; D M Lloyd-Jones
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

8.  Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.

Authors:  Donghee Kim; Andrew A Li; Chiranjeevi Gadiparthi; Muhammad Ali Khan; George Cholankeril; Jeffrey S Glenn; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2018-09-01       Impact factor: 22.682

9.  Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Taeang Arai; Masanori Atsukawa; Akihito Tsubota; Tadamichi Kawano; Mai Koeda; Yuji Yoshida; Tomohide Tanabe; Tomomi Okubo; Korenobu Hayama; Ai Iwashita; Norio Itokawa; Chisa Kondo; Keiko Kaneko; Chiaki Kawamoto; Tsutomu Hatori; Naoya Emoto; Etsuko Iio; Yasuhito Tanaka; Katsuhiko Iwakiri
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

10.  Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Do Seon Song; U Im Chang; Sung-Goo Kang; Sang-Wook Song; Jin Mo Yang
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519
  10 in total
  1 in total

Review 1.  Current Concepts of Cirrhotic Cardiomyopathy.

Authors:  Manhal J Izzy; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2021-03-10       Impact factor: 6.126
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.